Cost-effectiveness of adjuvant therapy for stage IIIA melanoma is poor even when patients are risk-stratified by gene expression profile Meeting Abstract
| Authors: | Hu, Y.; Briggs, A.; Marchetti, M.; Coit, D.; Bartlett, E. |
| Abstract Title: | Cost-effectiveness of adjuvant therapy for stage IIIA melanoma is poor even when patients are risk-stratified by gene expression profile |
| Meeting Title: | 2019 Annual Clinical Congress of the American College of Surgeons |
| Journal Title: | Journal of the American College of Surgeons |
| Volume: | 229 |
| Issue: | 4 Suppl. 2 |
| Meeting Dates: | 2019 Oct 27-31 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1072-7515 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | e53 |
| Language: | English |
| ACCESSION: | WOS:000492749600114 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jamcollsurg.2019.08.770 |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
